Goldstein Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1963807 Madison, WI

Position in JNJ

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,002,419

+$123,413 QoQ

Shares Held

3,947

+9.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.98%

of 13F equity value

Holder Rank

#3,011

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Goldstein Advisors, LLC holds $3,737,042 across 6 Drug Manufacturers - General names. JNJ ranks #1 (26.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	3,947	$1,002,419
2	ABBV	AbbVie Inc.	3,951	$994,229
3	LLY	ELI LILLY & Co	525	$629,700
4	MRK	Merck & Co., Inc.	4,434	$569,769
5	GILD	Gilead Sciences, Inc.	2,555	$322,798
6	NVO	Novo Nordisk A S	4,550	$218,127

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,002,419	3,947	+9.8%	Shares	Sole	2026-07-20
2026-03-31	$879,006	3,596	+1.1%	Shares	Sole	2026-04-28
2025-12-31	$735,914	3,556	+0.2%	Shares	Sole	2026-02-10
2025-09-30	$658,241	3,550	-1.9%	Shares	Sole	2025-10-21
2025-06-30	$552,802	3,619	-1.0%	Shares	Sole	2025-07-29
2025-03-31	$605,979	3,654	-14.5%	Shares	Sole	2025-04-23
2024-12-31	$618,250	4,275	-4.9%	Shares	Sole	2025-01-17
2024-09-30	$728,459	4,495	+0.4%	Shares	Sole	2024-10-24
2024-06-30	$654,358	4,477	+26.8%	Shares	Sole	2024-07-24
2024-03-31	$558,410	3,530	+3.6%	Shares	Sole	2024-05-13
2023-12-31	$534,169	3,408	+0.9%	Shares	Sole	2024-02-12
2023-09-30	$526,279	3,379	-7.7%	Shares	Sole	2023-10-18
2023-06-30	$605,968	3,661	-0.2%	Shares	Sole	2023-07-21
2023-03-31	$568,695	3,669	+3.4%	Shares	Sole	2023-05-09
2022-12-31	$626,754	3,548	—	Shares	Sole	2023-02-03
No filing history on record for this holder in this stock.